Chronic Kidney Disease stage3 Clinical Trial
Official title:
Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome
This study is part of the RHU INNOV-CKD, winner of the 2019 call for projects. Its aim is to develop two biomarker assays to assess the thrombotic and haemorrhagic risks in patients with stage 3A or more severe chronic kidney disease (CKD) treated with percutaneous coronary intervention (PCI) and antiplatelet therapy following an acute coronary syndrome (ACS). We believe that these tests will help to adapt antiplatelet therapy on an individual basis (in terms of intensity and duration of treatment) and thus reduce the risk of thrombotic and haemorrhagic events in this particularly fragile population. The first biomarker corresponds to an intra-platelet molecule, Rap1b in its active form (known as aRap1b). The second is the pro-antithrombotic balance of circulating endothelial microvesicles (patEMV), which reflects endothelial dysfunction. An automated method for measuring these biomarkers will be developed in partnership with the D.Stago and BioCytex industries during the course of the project.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05630729 -
Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management
|
N/A | |
| Withdrawn |
NCT03998917 -
Pathophysiological Characterization of the Neuromuscular Function of a Population With Multiple Comorbidities Suffering From Chronic Renal Failure in Pre-dialysis.
|
||
| Completed |
NCT05153174 -
Study of Sulphoraphane in Chronic Kidney Disease
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03582982 -
Flywheel Exercise for CKD
|
N/A | |
| Not yet recruiting |
NCT06094920 -
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
|
Phase 4 | |
| Recruiting |
NCT05543928 -
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
|
Phase 3 | |
| Active, not recruiting |
NCT04264403 -
Renal Denervation in Chronic Kidney Disease - RDN-CKD Study
|
N/A | |
| Active, not recruiting |
NCT06037265 -
PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System
|
N/A | |
| Completed |
NCT04617431 -
Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients
|
N/A | |
| Recruiting |
NCT04961931 -
Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney Disease
|
N/A | |
| Recruiting |
NCT04336033 -
Validation and Evaluation of a Newly Developed Mobile Diet App
|
N/A | |
| Recruiting |
NCT05138419 -
A Pragmatic Approach to CKD Patient Education
|
N/A | |
| Completed |
NCT05264584 -
Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
|
N/A | |
| Not yet recruiting |
NCT06394544 -
Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment
|
N/A | |
| Recruiting |
NCT01410617 -
The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04827290 -
Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease
|
N/A | |
| Not yet recruiting |
NCT04311645 -
Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous
|
Phase 2 | |
| Completed |
NCT06293092 -
Effect of Intradialytic Exercises in Chronic Kidney Disease Patients
|
N/A | |
| Completed |
NCT03078101 -
EMPRA (EMPagliflozin and RAs in Kidney Disease)
|
Phase 2 | |
| Completed |
NCT03144635 -
A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir
|
Phase 4 |